Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies

k2hv news

Apr 25

Written By MacDougall Creative

MacDougall Creative https://www.macbiocom.com

Inspirna Appoints Dr. Usman “Oz” Azam, M.D., as New Chief Executive Officer

Harpoon Therapeutics Announces Closing of $25 Million Private Placement